JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 85 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $39,523 | -57.0% | 35,606 | +222.1% | 0.00% | – |
| Q4 2021 | $92,000 | -11.5% | 11,054 | -20.7% | 0.00% | – |
| Q3 2021 | $104,000 | -76.1% | 13,942 | -78.2% | 0.00% | -100.0% |
| Q2 2021 | $435,000 | +250.8% | 63,965 | +429.8% | 0.00% | +100.0% |
| Q1 2021 | $124,000 | -79.4% | 12,074 | -85.9% | 0.00% | -75.0% |
| Q4 2020 | $602,000 | +130.7% | 85,934 | +169.1% | 0.00% | 0.0% |
| Q3 2020 | $261,000 | +1.2% | 31,937 | -58.2% | 0.00% | +33.3% |
| Q4 2018 | $258,000 | +76.7% | 76,457 | +239.7% | 0.00% | +50.0% |
| Q3 2018 | $146,000 | – | 22,509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |